GTX Inc (GTXI) 0.60 $GTXI
Cyberonics: VNS Therapy Strong, Reimbursement Woes Stay - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 30, 1:30PM CST
On Dec 29, we issued an updated research report on Cyberonics Inc. (CYBX).
GTXI: 0.60 (-0.08), ACOR: 36.14 (-0.51), AFFX: 11.45 (+0.02), CYBX: 57.03 (+0.26)
Qiagen Poised on Molecular Diagnostics, International Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 30, 1:20PM CST
On Dec 30, we issued an updated research report on Qiagen N.V. (QGEN).
GTXI: 0.60 (-0.08), QGEN: 23.68 (-0.06), ACOR: 36.14 (-0.51), AFFX: 11.45 (+0.02)
Will GTx (GTXI) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 7:23AM CST
Will GTx (GTXI) Continue to Surge Higher?
GTXI: 0.60 (-0.08)
GTx Down 8.6%, Shares Slide into the Red (GTXI)
Comtex SmarTrend(R) - Fri Dec 19, 12:41PM CST
GTx (NASDAQ:GTXI) is one of today's worst performing penny stocks, down 8.6% to $0.89 on 1.1x average daily volume. Thus far today, GTx has traded 225,000 shares, vs. average volume of 204,000 shares per day. The stock has underperformed the Dow (-8.6% to the Dow's 0.0%) and underperformed the S&P 500 (-8.6% to the S&P's 0.2%) during today's trading.
GTXI: 0.60 (-0.08)
Strength Seen in GTX Inc (GTXI): Stock Rises 10.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 8:46AM CST
GTX Inc. (GTXI) was a big mover last session, with shares rising roughly 11% on the day.
BIIB: 391.66 (-0.45), GTXI: 0.60 (-0.08), ANIP: 62.69 (-0.43), AFFX: 11.45 (+0.02)
GTx to Present Results on Enobosarm 9mg in Women with Metastatic Breast Cancer at 2014 San Antonio Breast Cancer Symposium
Business Wire - Mon Dec 08, 7:01AM CST
GTx, Inc. (NASDAQ: GTXI) today announced that the results from its positive proof of concept Phase 2 clinical trial evaluating enobosarm 9mg in post-menopausal women with estrogen receptor (ER) positive and androgen receptor (AR) positive metastatic breast cancer will be featured in a poster presentation at the San Antonio Breast Cancer Symposium taking place December 9 - 13, 2014, in San Antonio, Texas.
GTXI: 0.60 (-0.08)
GTx's USD43.4m private placement closed
M2 - Tue Nov 18, 4:30AM CST
GTx Inc (Nasdaq:GTXI), a biopharmaceutical company, announced on Monday the closing of a private placement of its common stock and warrants to purchase its common stock.
GTXI: 0.60 (-0.08)
GTx Announces Closing of $43.4 Private Placement
Business Wire - Mon Nov 17, 6:00AM CST
GTx, Inc. (NASDAQ: GTXI) today announced that it has closed the previously-announced private placement of its common stock and warrants to purchase its common stock. In the private placement, GTx sold 64,311,112 immediately separable units, comprised of an aggregate of 64,311,112 newly-issued shares of common stock and warrants to purchase up to 64,311,112 additional shares of common stock, for an aggregate purchase price of approximately $43.4 million. Net proceeds to GTx from the private placement are expected to be approximately $42.8 million.
GTXI: 0.60 (-0.08)
GTx Announces Webcast of Corporate Presentation at the Stifel 2014 Healthcare Conference
Business Wire - Wed Nov 12, 6:30AM CST
GTx, Inc. (Nasdaq: GTXI) announced today that management will present a company overview on November 18, 2014, at the Stifel 2014 Healthcare Conference in New York City. The GTx presentation will begin at 3:00 pm EST. A simultaneous webcast of the presentation will be accessible from the GTx website at http://www.gtxinc.com. An archived replay of the presentation will be available on the company website until December 2.
GTXI: 0.60 (-0.08)
GTx's (GTXI) CEO Marc Hanover on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 12:14PM CST
GTXI: 0.60 (-0.08)
GTx net loss improves in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 10:51AM CST
GTXI: 0.60 (-0.08)
GTx (GTXI) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Nov 10, 7:55AM CST
GTXI: 0.60 (-0.08)
GTx beats by $0.05
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 6:18AM CST
GTXI: 0.60 (-0.08)
GTx Provides Corporate Update and Reports Third Quarter 2014 Financial Results
Business Wire - Mon Nov 10, 6:15AM CST
--Closing of recently announced private placement will provide cash through 2016 and key breast cancer milestones
GTXI: 0.60 (-0.08)
GTx Announces $43.4 Million Private Placement
Business Wire - Mon Nov 10, 6:01AM CST
GTx, Inc. (NASDAQ: GTXI) today announced that it has entered into a securities purchase agreement for the sale of approximately $43.4 million of its common stock and warrants to purchase common stock in a private placement. The group of accredited investors includes Biotechnology Value Fund, L. P. and other affiliates of BVF Partners L.P., certain existing GTx stockholders and certain members of the GTx management team and board of directors.
GTXI: 0.60 (-0.08)
Notable earnings before Monday’s open
Seeking Alpha - at Seeking Alpha - Sun Nov 09, 4:30PM CST
BID: 44.89 (-0.19), CRIS: 3.23 (+0.25), KWK: 0.15 (unch), ARQL: 1.35 (+0.04), CACQ: 7.72 (+0.12), RIG: 19.05 (+0.42), TRQ: 3.06 (unch), MPAA: 24.08 (-0.05), RSPP: 28.48 (+1.29), DF: 16.19 (-0.11), ENTR: 2.92 (unch), TA: 13.30 (+0.08), DDD: 32.81 (+0.40), RYN: 28.02 (-1.15), GAS: 50.07 (+0.27), CMCM: 20.20 (+0.10), LIOX: 5.57 (+0.10), WWAV: 38.65 (+0.61), ZINC: 13.95 (+0.26), GTXI: 0.60 (-0.08), GOGO: 16.08 (+0.44), RIGP: 15.88 (+0.63), EVEP: 16.83 (+0.26), SNSS: 2.28 (+0.01), MGIC: 6.40 (+0.03)
GTx, Inc. To Host Third Quarter 2014 Financial Results Conference Call and Webcast
Business Wire - Mon Nov 03, 4:00PM CST
GTx, Inc. (NASDAQ: GTXI) today announced that it will host a conference call and webcast to provide a corporate update and discuss the Company's third quarter 2014 financial results on Monday, November 10 at 9:00 a.m. Eastern Time. The call and webcast will follow the release of the financial results earlier that day.
GTXI: 0.60 (-0.08)
Hot Stock: GTx, Shares Drop 6.4% (GTXI)
Comtex SmarTrend(R) - Wed Sep 17, 10:37AM CDT
GTx (NASDAQ:GTXI) is one of today's worst performing penny stocks, down 6.4% to $0.74 on 1.4x average daily volume. GTx has traded 302,000 shares thus far today, vs. average volume of 215,000 shares per day. The stock has underperformed the Dow (-6.3% to the Dow's 0.1%) and underperformed the S&P 500 (-6.3% to the S&P's 0.1%) during today's trading.
GTXI: 0.60 (-0.08)
GTx Announces Webcast of Corporate Presentation at the 2014 Wedbush Pacgrow Life Sciences Management Access Conference
Business Wire - Thu Aug 07, 6:30AM CDT
GTx, Inc. (Nasdaq: GTXI) announced today that management will present a company overview on August 13, 2014, at the 2014 Wedbush Pacgrow Life Sciences Management Access Conference in New York City. The GTx presentation will begin at 2:30 pm EST. A simultaneous webcast of the presentation will be accessible from the GTx website at http://www.gtxinc.com. An archived replay of the presentation will be available on the company website until August 27.
GTXI: 0.60 (-0.08)
Investors look to Lighten Up on Shares of GTx, Shares Down 7.8% (GTXI)
Comtex SmarTrend(R) - Wed Aug 06, 12:42PM CDT
GTx (NASDAQ:GTXI) is one of today's worst performing low-priced stocks, down 7.8% to $1.06 on 1.1x average daily volume. GTx has traded 448,000 shares thus far today, vs. average volume of 419,000 shares per day. The stock has underperformed the Dow (-7.8% to the Dow's 0.2%) and underperformed the S&P 500 (-7.8% to the S&P's 0.2%) during today's trading.
GTXI: 0.60 (-0.08)
Cyberonics: VNS Therapy Strong, Reimbursement Woes Stay - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 30, 1:30PM CST
On Dec 29, we issued an updated research report on Cyberonics Inc. (CYBX).
GTXI: 0.60 (-0.08), ACOR: 36.14 (-0.51), AFFX: 11.45 (+0.02), CYBX: 57.03 (+0.26)
Qiagen Poised on Molecular Diagnostics, International Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 30, 1:20PM CST
On Dec 30, we issued an updated research report on Qiagen N.V. (QGEN).
GTXI: 0.60 (-0.08), QGEN: 23.68 (-0.06), ACOR: 36.14 (-0.51), AFFX: 11.45 (+0.02)
Will GTx (GTXI) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 7:23AM CST
Will GTx (GTXI) Continue to Surge Higher?
GTXI: 0.60 (-0.08)
GTx Down 8.6%, Shares Slide into the Red (GTXI)
Comtex SmarTrend(R) - Fri Dec 19, 12:41PM CST
GTx (NASDAQ:GTXI) is one of today's worst performing penny stocks, down 8.6% to $0.89 on 1.1x average daily volume. Thus far today, GTx has traded 225,000 shares, vs. average volume of 204,000 shares per day. The stock has underperformed the Dow (-8.6% to the Dow's 0.0%) and underperformed the S&P 500 (-8.6% to the S&P's 0.2%) during today's trading.
GTXI: 0.60 (-0.08)
Strength Seen in GTX Inc (GTXI): Stock Rises 10.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 8:46AM CST
GTX Inc. (GTXI) was a big mover last session, with shares rising roughly 11% on the day.
BIIB: 391.66 (-0.45), GTXI: 0.60 (-0.08), ANIP: 62.69 (-0.43), AFFX: 11.45 (+0.02)
GTx to Present Results on Enobosarm 9mg in Women with Metastatic Breast Cancer at 2014 San Antonio Breast Cancer Symposium
Business Wire - Mon Dec 08, 7:01AM CST
GTx, Inc. (NASDAQ: GTXI) today announced that the results from its positive proof of concept Phase 2 clinical trial evaluating enobosarm 9mg in post-menopausal women with estrogen receptor (ER) positive and androgen receptor (AR) positive metastatic breast cancer will be featured in a poster presentation at the San Antonio Breast Cancer Symposium taking place December 9 - 13, 2014, in San Antonio, Texas.
GTXI: 0.60 (-0.08)
GTx's USD43.4m private placement closed
M2 - Tue Nov 18, 4:30AM CST
GTx Inc (Nasdaq:GTXI), a biopharmaceutical company, announced on Monday the closing of a private placement of its common stock and warrants to purchase its common stock.
GTXI: 0.60 (-0.08)
GTx Announces Closing of $43.4 Private Placement
Business Wire - Mon Nov 17, 6:00AM CST
GTx, Inc. (NASDAQ: GTXI) today announced that it has closed the previously-announced private placement of its common stock and warrants to purchase its common stock. In the private placement, GTx sold 64,311,112 immediately separable units, comprised of an aggregate of 64,311,112 newly-issued shares of common stock and warrants to purchase up to 64,311,112 additional shares of common stock, for an aggregate purchase price of approximately $43.4 million. Net proceeds to GTx from the private placement are expected to be approximately $42.8 million.
GTXI: 0.60 (-0.08)
GTx Announces Webcast of Corporate Presentation at the Stifel 2014 Healthcare Conference
Business Wire - Wed Nov 12, 6:30AM CST
GTx, Inc. (Nasdaq: GTXI) announced today that management will present a company overview on November 18, 2014, at the Stifel 2014 Healthcare Conference in New York City. The GTx presentation will begin at 3:00 pm EST. A simultaneous webcast of the presentation will be accessible from the GTx website at http://www.gtxinc.com. An archived replay of the presentation will be available on the company website until December 2.
GTXI: 0.60 (-0.08)
GTx's (GTXI) CEO Marc Hanover on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 12:14PM CST
GTXI: 0.60 (-0.08)
GTx net loss improves in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 10:51AM CST
GTXI: 0.60 (-0.08)
GTx (GTXI) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Nov 10, 7:55AM CST
GTXI: 0.60 (-0.08)
GTx beats by $0.05
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 6:18AM CST
GTXI: 0.60 (-0.08)
GTx Provides Corporate Update and Reports Third Quarter 2014 Financial Results
Business Wire - Mon Nov 10, 6:15AM CST
--Closing of recently announced private placement will provide cash through 2016 and key breast cancer milestones
GTXI: 0.60 (-0.08)
GTx Announces $43.4 Million Private Placement
Business Wire - Mon Nov 10, 6:01AM CST
GTx, Inc. (NASDAQ: GTXI) today announced that it has entered into a securities purchase agreement for the sale of approximately $43.4 million of its common stock and warrants to purchase common stock in a private placement. The group of accredited investors includes Biotechnology Value Fund, L. P. and other affiliates of BVF Partners L.P., certain existing GTx stockholders and certain members of the GTx management team and board of directors.
GTXI: 0.60 (-0.08)
Notable earnings before Monday’s open
Seeking Alpha - at Seeking Alpha - Sun Nov 09, 4:30PM CST
BID: 44.89 (-0.19), CRIS: 3.23 (+0.25), KWK: 0.15 (unch), ARQL: 1.35 (+0.04), CACQ: 7.72 (+0.12), RIG: 19.05 (+0.42), TRQ: 3.06 (unch), MPAA: 24.08 (-0.05), RSPP: 28.48 (+1.29), DF: 16.19 (-0.11), ENTR: 2.92 (unch), TA: 13.30 (+0.08), DDD: 32.81 (+0.40), RYN: 28.02 (-1.15), GAS: 50.07 (+0.27), CMCM: 20.20 (+0.10), LIOX: 5.57 (+0.10), WWAV: 38.65 (+0.61), ZINC: 13.95 (+0.26), GTXI: 0.60 (-0.08), GOGO: 16.08 (+0.44), RIGP: 15.88 (+0.63), EVEP: 16.83 (+0.26), SNSS: 2.28 (+0.01), MGIC: 6.40 (+0.03)
GTx, Inc. To Host Third Quarter 2014 Financial Results Conference Call and Webcast
Business Wire - Mon Nov 03, 4:00PM CST
GTx, Inc. (NASDAQ: GTXI) today announced that it will host a conference call and webcast to provide a corporate update and discuss the Company's third quarter 2014 financial results on Monday, November 10 at 9:00 a.m. Eastern Time. The call and webcast will follow the release of the financial results earlier that day.
GTXI: 0.60 (-0.08)
Hot Stock: GTx, Shares Drop 6.4% (GTXI)
Comtex SmarTrend(R) - Wed Sep 17, 10:37AM CDT
GTx (NASDAQ:GTXI) is one of today's worst performing penny stocks, down 6.4% to $0.74 on 1.4x average daily volume. GTx has traded 302,000 shares thus far today, vs. average volume of 215,000 shares per day. The stock has underperformed the Dow (-6.3% to the Dow's 0.1%) and underperformed the S&P 500 (-6.3% to the S&P's 0.1%) during today's trading.
GTXI: 0.60 (-0.08)
GTx Announces Webcast of Corporate Presentation at the 2014 Wedbush Pacgrow Life Sciences Management Access Conference
Business Wire - Thu Aug 07, 6:30AM CDT
GTx, Inc. (Nasdaq: GTXI) announced today that management will present a company overview on August 13, 2014, at the 2014 Wedbush Pacgrow Life Sciences Management Access Conference in New York City. The GTx presentation will begin at 2:30 pm EST. A simultaneous webcast of the presentation will be accessible from the GTx website at http://www.gtxinc.com. An archived replay of the presentation will be available on the company website until August 27.
GTXI: 0.60 (-0.08)
Investors look to Lighten Up on Shares of GTx, Shares Down 7.8% (GTXI)
Comtex SmarTrend(R) - Wed Aug 06, 12:42PM CDT
GTx (NASDAQ:GTXI) is one of today's worst performing low-priced stocks, down 7.8% to $1.06 on 1.1x average daily volume. GTx has traded 448,000 shares thus far today, vs. average volume of 419,000 shares per day. The stock has underperformed the Dow (-7.8% to the Dow's 0.2%) and underperformed the S&P 500 (-7.8% to the S&P's 0.2%) during today's trading.
GTXI: 0.60 (-0.08)
